We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
10 Year Est. Return
AUM
$73.1M
AUM Growth
+$605K
Cap. Flow
-$2.6M
Cap. Flow %
-3.56%
Top 10 Hldgs %
36.25%
Holding
110
New
15
Increased
54
Reduced
24
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 42.72%
2 Healthcare 18.69%
3 Consumer Discretionary 9.1%
4 Financials 8.36%
5 Industrials 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
101
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$210K 0.29%
+2,533
New +$205K
WDAY icon
102
Workday
WDAY
$42B
$210K 0.29%
1,255
-170
-12% -$26.5K
ENB icon
103
Enbridge
ENB
$113B
$208K 0.28%
+5,328
New +$208K
SOFI icon
104
SoFi Technologies
SOFI
$23.4B
$137K 0.19%
29,745
+495
+2% +$2.46K
ABNB icon
105
Airbnb
ABNB
$90B
-2,561
Closed -$269K
AIVI icon
106
WisdomTree International AI Enhanced Value Fund
AIVI
$63.4M
-200
Closed -$6.09M
LITE icon
107
Lumentum
LITE
$65.2B
-3,974
Closed -$272K
U icon
108
Unity
U
$17.8B
-8,708
Closed -$277K
AVLR
109
DELISTED
Avalara, Inc.
AVLR
-3,535
Closed -$324K
BHVN
110
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-1,355
Closed -$204K

Similar funds

KRS Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, KRS Capital Management held 110 positions worth $73.1M, up 0.83% from $72.5M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

KRS Capital Management withdrew a net $2.6M in Q4 2022, closing 6 positions and reducing 24 holdings. Its most notable exit was WisdomTree International AI Enhanced Value Fund, an estimated $6.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, KRS Capital Management opened a new position in Merck worth $483K.

  • KRS Capital Management's largest Q4 2022 buy was Merck: 4,352 shares worth $483K.
  • KRS Capital Management added most to Eli Lilly in Q4 2022, an estimated $104K increase.
  • KRS Capital Management's biggest Q4 2022 reduction was Apple, cutting an estimated $146K.
  • KRS Capital Management fully exited WisdomTree International AI Enhanced Value Fund in Q4 2022, selling an estimated $6.09M.
  • KRS Capital Management's ten largest holdings make up 36% of its $73.1M portfolio in Q4 2022.
  • KRS Capital Management opened 15 new positions and closed 6 in Q4 2022.
  • KRS Capital Management's portfolio value rose 0.83% quarter-over-quarter to $73.1M.

Based on KRS Capital Management's 13F filing for Q4 2022, filed 19 Jan 2023.